<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
<channel>
    <title><![CDATA[EU/3/12/1043 (N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine to be used with folic acid) - Voisin Consulting S.A.R.L.]]></title>
    <ttl>1440</ttl>
    <copyright>Copyright: (C) European Commission</copyright>
    <language>en-gb</language>
    <atom:link href="http://ec.europa.eu/health/documents/community-register/html/rss/o1043.rss" rel="self" type="application/rss+xml" />
    <lastBuildDate>Mon, 22 May 2017 12:05:00 +0000</lastBuildDate>
    <link>http://ec.europa.eu/health/documents/community-register/html/o1043.htm</link>
    <description><![CDATA[EU/3/12/1043 (Active substance: N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine to be used with folic acid) - EU number: EU/3/12/1043 - Marketing authorisation holder: Voisin Consulting S.A.R.L.]]>
    </description>
    <image>
        <title><![CDATA[EU/3/12/1043 (N-[4-[[(2-amino-3,4-dihydro-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-D-gamma-glutamyl-(2S)-2-amino-beta-alanyl-L-alpha-aspartyl-L-cysteine to be used with folic acid) - Voisin Consulting S.A.R.L.]]></title>
        <url>http://ec.europa.eu/health/documents/community-register/images/logo_en.gif</url>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1043.htm</link>
        <width>144</width>
        <height>100</height>
    </image>
    <item>
        <title>Change of name and/or address of sponsor - No Commission Decision</title>
        <category>No new document</category>
        <guid isPermaLink="true">http://ec.europa.eu/health/documents/community-register/html/o1043.htm#proc138138</guid>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1043.htm#proc138138</link>
        <description><![CDATA[Change of name and/or address of sponsor) - No Commission Decision]]></description>
        <pubDate>Mon, 22 May 2017 12:05:00 +0000</pubDate>
    </item>
    <item>
        <title>Transfer of orphan designation - Commission Decision (2016)8910 of Wed, 21 Dec 2016</title>
        <category>New documents</category>
        <guid isPermaLink="true">http://ec.europa.eu/health/documents/community-register/html/o1043.htm#proc136731</guid>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1043.htm#proc136731</link>
        <description><![CDATA[Transfer of orphan designation) - Commission Decision (2016)8910 of Wed, 21 Dec 2016 - European Medicines Agency (EMA) procedure number: EMA/OD/055/12/T/01]]></description>
        <pubDate>Wed, 21 Dec 2016 12:12:00 +0000</pubDate>
    </item>
    <item>
        <title>Orphan designation - Commission Decision (2012)6369 of Wed, 12 Sep 2012</title>
        <category>New documents</category>
        <guid isPermaLink="true">http://ec.europa.eu/health/documents/community-register/html/o1043.htm#proc124056</guid>
        <link>http://ec.europa.eu/health/documents/community-register/html/o1043.htm#proc124056</link>
        <description><![CDATA[Orphan designation) - Commission Decision (2012)6369 of Wed, 12 Sep 2012 - European Medicines Agency (EMA) procedure number: EMA/OD/055/12]]></description>
        <pubDate>Wed, 12 Sep 2012 12:09:00 +0000</pubDate>
    </item>
    </channel>
</rss>
